Score Your Stock

US stock · figures in US dollars · scored on full-year results

Charles River Laboratories Charles River Laboratories International, Inc. Common Stock

CRL · Healthcare · Diagnostics & Research
Bottom 1% of scored stocks
WeakBottom 1% of scored stocks
Weak SpotRecent Loss

Charles River Laboratories scores 24/100 on fundamentals: in the bottom 1% of 503 scored S&P 500 stocks. Its strongest area is Cash & Dividends (50/100); its weakest is Business Strength (0/100). It carries 2 warning flags: Weak Spot, Recent Loss.

Best
Cash 50
Risk 50
Weakest
Business 0
Price 0
  • Carries a Weak Spot flag
  • Carries a Recent Loss flag

A financially stretched, expensively priced stock with shrinking sales, but business strength needs attention.

What looks good
What to watch
Mkt capUS$ 17.2b#432 of 503 in the S&P 500EPSUS$ -4.80P/En/m (loss-making)P/B6×✗ vs sector median 3.7×Div yieldNo dividends paidBottom 14% in the S&P 50052w range · 91% of range146.20379.63
as of 31 Oct 2026

Nearby peers

Ranks #59 of 60 in Healthcare by score

#1Universal Health Services79#56Henry Schein35#57Becton Dickinson31#58Gilead Sciences31
#59Charles River Laboratories24
#60Moderna21

One-Minute Summary

Why Charles River Laboratories scores 24

A financially stretched, expensively priced stock with shrinking sales, but business strength needs attention.

What looks good
What to watch

Business Strength

0
Why 0?
Pillar score: (0 + 0 + 0 + 0 + 0) = 0 of 10 points → 0
Return on Equity (ROE)-8%Weak4-Year Revenue Growth-1%/yrWeak4-Year Profit Growthn/m (loss-making)WeakNet Profit Marginn/m (loss-making)WeakQuarterly Momentumn/m (loss-making)Weak
Show 3 charts

Net Profit & Equity, with ROE

Net Profit ↓ -150.3%Equity ↓ -21.1%ROE % -8.4%
Net ProfitEquityROE %
475m10m-144m-238m3.6b3.5b3.2b2.8b202320242025TTM13.2%0.3%-4.6%-8.4%

Revenue & Net Profit, with Net Margin

Revenue ↓ -3.2%Net Profit ↓ -150.3%Net Margin % -6%
RevenueNet ProfitNet Margin %
4.1b4.0b4.0b4.0b475m10m-144m-238m202320242025TTM11.5%0.3%-3.6%-6%

Sales have been roughly flat for 4 years: the business isn't really growing, just maintaining.

The company lost money in recent years: the bars below zero are losses, not profits.

Recent Quarters: Revenue & Net Profit (the last 8 quarters, scored)

Revenue → -0.6%Net Profit ↓ -102.1%Net Margin % -0.1%
RevenueNet ProfitNet Margin %
1.0b1.0b984m1.0b1.0b994m996m1.0b70m-214m26m52m54m-277m-15m-1mQ3'24Q4'24Q1'25Q2'25Q3'25Q4'25Q1'26Q2'267%-21.3%2.6%5.1%5.4%-27.8%-1.5%-0.1%
▼▼▼▼▼▼▼▼

Sales have stayed roughly flat over the last 8 quarters.

The company made a loss in at least one of the last 8 quarters: the bars below zero are losses, not profits.

Why 17?
Pillar score: (0 + 1 + 0) = 1 of 6 points → 17
Debt-to-Equity1.1×WeakCurrent Ratio1.4×OkayInterest Coverage-0.7×Weak
Show 2 charts

Debt vs Equity, with D/E ratio

Total Debt → -1.3%Equity ↓ -21.1%D/E 1.1×
Total DebtEquityD/E
3.1b2.7b2.6b3.0b3.6b3.5b3.2b2.8b202320242025TTM0.9×0.8×0.8×1.1×

Borrowings have stayed roughly level: manageable, as long as profits stay healthy.

Short-term assets vs bills, with Current Ratio

Current Assets ↓ -4.9%Current Liabilities ↑ +7.5%Current Ratio 1.3×
Current AssetsCurrent LiabilitiesCurrent Ratio
1.6b1.4b1.4b1.5b1.1b994m1.1b1.1b202320242025TTM1.5×1.4×1.3×1.3×
Why 50?
Pillar score: (0 + 1 + 2 + 1) = 4 of 8 points → 50
Dividend QualityNo dividends paidWeak
Payout ratio: -0%
Operating Cash FlowPositive but bumpyOkayFree Cash FlowPositive & growingStrongCash & Cash EquivalentsPartly healthyOkay
Show 3 charts

Operating vs Free Cash Flow

Operating CF ↓ -14.9%Free CF → +1.4%
Operating CFFree CF
684m735m738m582m365m502m519m371m202320242025TTM

Cash keeps coming in, though unevenly: fine, but worth keeping an eye on.

Cash vs Total Debt

Cash ↓ -30.6%Total Debt → -1.3%
CashTotal Debt
277m195m214m192m3.1b2.7b2.6b3.0b202320242025TTM

Dividends per Share, with Yield

DPS (cents) → +0%Yield % 0%
DPS (cents)Yield %
000020222023202420250%0%0%0%

Dividends per share have been maintained or raised: management shares the rewards with you.

Why 0?
Pillar score: (0 + 0 + 0) = 0 of 6 points → 0
P/E Ration/m (loss-making)WeakP/B Ratio6×WeakPEG Ration/m (growth not measurable)Weak
Show chart

Share Price: Weekly Closes (not part of the score)

US$ 359.41US$ 255.13US$ 150.85Oct '25Feb '26Jun '26Oct '26

The share price is up about 99.6% over the past year.

Why 50?
Pillar score: (0 + 1 + 2 + 2 + 1 + 0) = 6 of 12 points → 50
Earnings ConsistencyVery bumpyWeakDebt Trend (4yr)StableOkayShare Count Trend (4yr)-2%/yrStrongInventory vs Sales (4yr)-2 pp/yr vs salesStrongAsset Turnover Trend (4yr)+5.4%OkayQuarterly ConsistencyLoss in 4 of 8 quartersWeak
Show chart

Revenue vs Inventory, with Inventory % of Revenue

Revenue ↓ -3.2%Inventory ↓ -8.9%Inv. % of Rev. 8.7%
RevenueInventoryInv. % of Rev.
4.1b4.0b4.0b4.0b380m279m299m346m202320242025TTM9.2%6.9%7.4%8.7%
Ranks #59 of 60 in Healthcare by score

Sector peers

#1Universal Health Services79#56Henry Schein35#57Becton Dickinson31#58Gilead Sciences31
#59Charles River Laboratories (you)24
#60Moderna21

Full Financial History

Every reported figure behind the score, year by year. Download it, or check it against the company's own annual report.

Financial YearRevenueNet ProfitOperating Cash FlowFree Cash FlowCapExCashTotal DebtEquityCurrent AssetsCurrent LiabilitiesTotal AssetsTotal LiabilitiesInventoryDividendsReturn on Equity (ROE)Net Profit MarginDebt-to-EquityCurrent RatioInterest CoverageDiv yieldP/E RatioP/B RatioPEG Ratio
2026US$ 4.0bUS$ -238.5mUS$ 582.1mUS$ 370.6mUS$ -211.5mUS$ 192.0mUS$ 3.0bUS$ 2.8bUS$ 1.5bUS$ 1.1bUS$ 7.5bUS$ 4.6bUS$ 346.3m--8%-6%1.1×1.4×-0.7×----
2025US$ 4.0bUS$ -144.3mUS$ 737.6mUS$ 518.5mUS$ -219.2mUS$ 213.8mUS$ 2.6bUS$ 3.2bUS$ 1.4bUS$ 1.1bUS$ 7.1bUS$ 3.9bUS$ 299.1mUS$ 0.0m-5%-4%0.8×1.3×0.1×0%-69.0×3.2×-
2024US$ 4.0bUS$ 10.3mUS$ 734.6mUS$ 501.6mUS$ -233.0mUS$ 194.6mUS$ 2.7bUS$ 3.5bUS$ 1.4bUS$ 994.1mUS$ 7.5bUS$ 4.0bUS$ 278.5mUS$ 0.0m0%0%0.8×1.4×1.7×0%922.8×2.8×-
2023US$ 4.1bUS$ 474.6mUS$ 683.9mUS$ 365.4mUS$ -318.5mUS$ 276.8mUS$ 3.1bUS$ 3.6bUS$ 1.6bUS$ 1.1bUS$ 8.2bUS$ 4.5bUS$ 380.3mUS$ 0.0m13%11%0.9×1.5×5.3×0%25.6×3.4×2.8